Stephen Farrelly
Stephen Farrelly is the global head of pharma and healthcare at ING, where he analyzes market trends and their implications for consumers. He has highlighted that the imposition of tariffs on generic drugs could significantly increase costs for consumers, particularly those without insurance, who would be hit hardest by rising drug prices resulting from these tariffs.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
Stephen Farrelly, global head of pharma and healthcare at ING, said the people who would be 'hardest hit' were those without insurance.
6